** ASX-listed shares of Volpara Health Technologies VHT.AX
rise as much as 3.8% to A$0.680, their biggest intraday pct gain
since Feb 21
** New Zealand-based medical services provider says new
contract with Sutter Health for Risk Pathways product represents
an additional $900,000 in total contract value over 3 years
** Says new order expands existing contracted annual
recurring revenue to $374,000
** Adds, installation of Risk Pathways likely in the next 6
months
** Says contract expected to contribute to revenue growth in
FY24
** Stock has risen about 25% this year, as of last close
(Reporting by Echha Jain in Bengaluru)
((Echha.jain@thomsonreuters.com))